BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16775991)

  • 21. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
    Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
    Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].
    Boulanger JC; Fauvet R; Urrutiaguer S; Drean Y; Sevestre H; Ganry O; Bergeron C; Gondry J
    Gynecol Obstet Fertil; 2007 Sep; 35(9):764-71. PubMed ID: 17765001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing new technologies for cervical cancer screening: beyond sensitivity.
    Massad LS
    J Low Genit Tract Dis; 2008 Oct; 12(4):311-5. PubMed ID: 18820547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV and cervical cancer: updates on an established relationship.
    Subramanya D; Grivas PD
    Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer screening programs in Latin America and the Caribbean.
    Murillo R; Almonte M; Pereira A; Ferrer E; Gamboa OA; Jerónimo J; Lazcano-Ponce E
    Vaccine; 2008 Aug; 26 Suppl 11():L37-48. PubMed ID: 18945401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV testing for cervical cancer screening in Croatia.
    Grce M; Grahovac B; Rukavina T; Vrdoljak-Mozetic D; Glavas-Obrovac L; Kaliterna V; Zele-Starcević L
    Coll Antropol; 2007 Apr; 31 Suppl 2():67-71. PubMed ID: 17598507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
    Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organisation of cervical cytology screening in Croatia: past, present and future.
    Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
    Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
    Hølund B; Grinsted P
    Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disappointing effectiveness of population screening for cervical cancer].
    Giard RW; Coebergh JW; Wijnen JA
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):317-21. PubMed ID: 9132604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
    Reust CE
    J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for squamous cervical cancer--the duration of low risk following negative results in cervical cytology test: introduction. IARC Working Group on Cervical Cancer Screening.
    IARC Sci Publ; 1986; (76):15-24. PubMed ID: 3570401
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk-adapted multimodal laboratory cervical screening -- application of new technologies to cervical cancer prevention.
    Bollmann R; Bankfalvi A; Bollmann M
    Croat Med J; 2005 Jun; 46(3):361-7. PubMed ID: 15861512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reflections on cervical cancer.
    Lapointe PA
    Eur J Gynaecol Oncol; 2004; 25(6):671-2. PubMed ID: 15597840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for cervical cancer. Pap smears can save lives.
    Wong JG; Feussner JR
    N C Med J; 1993 Jul; 54(7):342-5. PubMed ID: 8350931
    [No Abstract]   [Full Text] [Related]  

  • 39. [New ways of cervical cancer screening].
    Teikari M
    Duodecim; 2004; 120(13):1595-6; discussion 1596-7. PubMed ID: 15326967
    [No Abstract]   [Full Text] [Related]  

  • 40. Cervical cytology service in Nigeria: providers' perspective.
    Adesina OA; Babarinsa IA; Fawole OA; Oladokun A; Adeniji AR; Adewole IF
    J Obstet Gynaecol; 2003 Jul; 23(4):416-8. PubMed ID: 12881085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.